Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-07-01 Sale | 2026-07-02 4:35 pm | GENELUX Corp | GNLX | Smither John W Director | 12,000 | $2.9082 | $34,898 | 91,403 (Direct) | View |
| 2026-06-03 Sale | 2026-06-04 8:35 pm | GENELUX Corp | GNLX | Smalling Ralph Head of Regulatory | 192 | $2.93 | $563 | 67,611 (Direct) | View |
| 2026-06-01 Sale | 2026-06-02 8:35 pm | GENELUX Corp | GNLX | Thomas John Director | 10,000 | $2.9801 | $29,801 | 472,784 (Direct) | View |
| 2026-05-11 Sale | 2026-05-12 8:30 pm | GENELUX Corp | GNLX | Yu Yong Chief Scientific Officer | 605 | $2.9726 | $1,798 | 149,706 (Direct) | View |
| 2026-05-11 Sale | 2026-05-12 8:30 pm | GENELUX Corp | GNLX | Cappello Joseph Chief Technical Officer | 605 | $2.9742 | $1,799 | 154,549 (Direct) | View |
| 2026-05-11 Sale | 2026-05-12 8:30 pm | GENELUX Corp | GNLX | Zindrick Thomas President and CEO | 2,798 | $2.9398 | $8,226 | 532,051 (Direct) | View |
| 2026-05-11 Sale | 2026-05-12 8:30 pm | GENELUX Corp | GNLX | Smalling Ralph Head of Regulatory | 270 | $2.9796 | $804 | 67,803 (Direct) | View |
| 2026-03-24 Sale | 2026-03-26 5:00 pm | GENELUX Corp | GNLX | Smalling Ralph Head of Regulatory | 585 | $2.4569 | $1,437 | 68,073 (Direct) | View |
| 2026-03-24 Sale | 2026-03-26 5:00 pm | GENELUX Corp | GNLX | Cappello Joseph Chief Technical Officer | 906 | $2.42 | $2,193 | 155,154 (Direct) | View |
| 2026-03-24 Sale | 2026-03-26 5:00 pm | GENELUX Corp | GNLX | Yu Yong SVP, Clinical Development | 906 | $2.42 | $2,193 | 144,938 (Direct) | View |
| 2026-03-24 Sale | 2026-03-26 5:00 pm | GENELUX Corp | GNLX | Zindrick Thomas President and CEO | 3,582 | $2.42 | $8,668 | 534,849 (Direct) | View |
| 2026-03-02 Sale | 2026-03-03 8:05 pm | GENELUX Corp | GNLX | Thomas John Director | 10,000 | $2.8957 | $28,957 | 482,784 (Direct) | View |
| 2025-08-21 Sale | 2025-12-11 8:50 pm | GENELUX Corp | GNLX | Yu Yong SVP, Clinical Development | 4,192 | $3.8244 | $16,032 | 145,844 (Direct) | View |
| 2025-08-21 Sale | 2025-12-11 8:50 pm | GENELUX Corp | GNLX | Zindrick Thomas President and CEO | 17,182 | $3.8628 | $66,370 | 538,431 (Direct) | View |
| 2025-08-21 Sale | 2025-12-11 8:49 pm | GENELUX Corp | GNLX | Cappello Joseph Chief Technical Officer | 3,706 | $3.8751 | $14,361 | 156,060 (Direct) | View |
| 2025-08-21 Sale | 2025-12-09 8:00 pm | GENELUX Corp | GNLX | Smalling Ralph Head of Regulatory | 2,332 | $3.748 | $8,740 | 68,658 (Direct) | View |
| 2025-12-01 Sale | 2025-12-02 7:00 pm | GENELUX Corp | GNLX | Thomas John Director | 10,000 | $5.0008 | $50,008 | 492,784 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-06-16 Option Award | 2026-06-18 7:05 pm | N/A N/A | GENELUX Corp | GNLX | Pulisic Matthew Chief Financial Officer | 278,906 | $0 | 278,906 (Direct) | View |
| 2026-06-16 Option Award | 2026-06-18 7:05 pm | N/A N/A | GENELUX Corp | GNLX | Groen Eric General Counsel | 233,957 | $0 | 233,957 (Direct) | View |
| 2026-06-16 Option Award | 2026-06-18 7:05 pm | N/A N/A | GENELUX Corp | GNLX | Cappello Joseph Chief Technical Officer | 174,841 | $0 | 329,390 (Direct) | View |
| 2026-06-16 Option Award | 2026-06-18 7:05 pm | N/A 2036-06-15 | GENELUX Corp | GNLX | Tyree James L Director | 59,975 | $0 | 128,049 (Direct) | View |
| 2026-06-16 Option Award | 2026-06-18 7:05 pm | N/A N/A | GENELUX Corp | GNLX | Zindrick Thomas President and CEO | 730,601 | $0 | 1,263,913 (Direct) | View |
| 2026-06-16 Option Award | 2026-06-18 7:05 pm | N/A 2036-06-15 | GENELUX Corp | GNLX | Thomas John Director | 59,975 | $0 | 532,759 (Direct) | View |
| 2026-06-16 Option Award | 2026-06-18 7:05 pm | N/A 2036-06-15 | GENELUX Corp | GNLX | Mirabelli Mary Director | 59,975 | $0 | 134,259 (Direct) | View |
| 2026-06-16 Option Award | 2026-06-18 7:05 pm | N/A N/A | GENELUX Corp | GNLX | Yu Yong Chief Scientific Officer | 119,318 | $0 | 269,024 (Direct) | View |
| 2026-06-16 Option Award | 2026-06-18 7:05 pm | N/A 2036-06-15 | GENELUX Corp | GNLX | Smither John W Director | 59,975 | $0 | 134,969 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-07 5:32 pm | N/A 2036-01-01 | GENELUX Corp | GNLX | Litten Jason Chief Medical Officer | 275,000 | $0 | 275,000 (Direct) | View |
| 2025-09-01 Option Award | 2025-09-03 4:15 pm | N/A 2027-09-18 | GENELUX Corp | GNLX | Zindrick Thomas President and CEO | 1,355,940 | $0 | 1,355,940 (Direct) | View |
| 2025-09-01 Option Award | 2025-09-03 4:15 pm | N/A 2029-09-20 | GENELUX Corp | GNLX | Yu Yong SVP, Clinical Development | 272,652 | $0 | 272,652 (Direct) | View |
| 2025-09-01 Option Award | 2025-09-03 4:15 pm | N/A 2030-09-23 | GENELUX Corp | GNLX | Smalling Ralph Head of Regulatory | 18,333 | $0 | 79,323 (Direct) | View |
| 2025-09-01 Option Award | 2025-09-03 4:15 pm | N/A 2026-12-30 | GENELUX Corp | GNLX | Cappello Joseph Chief Technical Officer | 174,999 | $0 | 174,999 (Direct) | View |
| 2025-08-27 Option Award | 2025-08-29 4:30 pm | N/A 2035-08-26 | GENELUX Corp | GNLX | Thomas John Director | 50,859 | $0 | 531,360 (Direct) | View |
| 2025-08-27 Option Award | 2025-08-29 4:30 pm | N/A 2035-08-26 | GENELUX Corp | GNLX | Zindrick Thomas President and CEO | 840,000 | $0 | 1,032,961 (Direct) | View |
| 2025-08-27 Option Award | 2025-08-29 4:30 pm | N/A 2035-08-26 | GENELUX Corp | GNLX | Smalling Ralph Head of Regulatory | 61,000 | $0 | 95,760 (Direct) | View |
| 2025-08-27 Option Award | 2025-08-29 4:30 pm | N/A 2035-08-26 | GENELUX Corp | GNLX | Smither John W Director | 50,859 | $0 | 103,570 (Direct) | View |
| 2025-08-27 Option Award | 2025-08-29 4:30 pm | N/A 2035-08-26 | GENELUX Corp | GNLX | Yu Yong SVP, Clinical Development | 236,000 | $0 | 284,556 (Direct) | View |
| 2025-08-27 Option Award | 2025-08-29 4:30 pm | N/A 2035-08-26 | GENELUX Corp | GNLX | Mirabelli Mary Director | 50,859 | $0 | 101,860 (Direct) | View |
| 2025-08-27 Option Award | 2025-08-29 4:30 pm | N/A 2035-08-26 | GENELUX Corp | GNLX | Tyree James L Director | 50,859 | $0 | 96,650 (Direct) | View |
| 2025-08-27 Option Award | 2025-08-29 4:30 pm | N/A 2035-08-26 | GENELUX Corp | GNLX | Cappello Joseph Chief Technical Officer | 250,000 | $0 | 302,266 (Direct) | View |